That is not better than to use restenosis as controls. How would you know if somebody gets a restenosis one day after treatment? You will have to wait a pre-defined period or until he request a new test to find the restenosis, and then he should be removed from the "treatement arm".CureIous wrote:
That's precisely how Stanford is proposing to structure their study. The patient won't know if the balloon was fully inflated or not. All patients post-study that were in the "non-inflated" category will then have the option of getting the real deal. Simple and eloquent.
Mark
Then, why not treat everybody and just compare the de-stenosed and the restenosis groups? We only need to prove that blood flow affects the health of MS patients.